The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers

[1]  M. Tyers,et al.  The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent phosphorylation. , 1998, Molecular cell.

[2]  M. Ljungman.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. , 2000, Neoplasia.

[3]  K. Gould,et al.  Fission yeast Clp1p phosphatase affects G2/M transition and mitotic exit through Cdc25p inactivation , 2004, The EMBO journal.

[4]  A. Gartner,et al.  The CeCDC-14 phosphatase is required for cytokinesis in the Caenorhabditis elegans embryo , 2002, The Journal of cell biology.

[5]  M. Ljungman,et al.  The cyclin-dependent kinase inhibitor roscovitine inhibits RNA synthesis and triggers nuclear accumulation of p53 that is unmodified at Ser15 and Lys382. , 2001, Molecular pharmacology.

[6]  Angelika Amon,et al.  Cfi1 prevents premature exit from mitosis by anchoring Cdc14 phosphatase in the nucleolus , 1999, Nature.

[7]  A. Amon,et al.  MEN and SIN: what's the difference? , 2001, Nature Reviews Molecular Cell Biology.

[8]  P. Meraldi,et al.  Centrosome cohesion is regulated by a balance of kinase and phosphatase activities. , 2001, Journal of cell science.

[9]  D. Morgan,et al.  Pds 1 and Esp 1 control both anaphase and mitotic exit in normal cells and after DNA damage , 1999 .

[10]  G. Woude,et al.  Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.

[11]  D. Price,et al.  Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase* , 1996, The Journal of Biological Chemistry.

[12]  Kaori Sasai,et al.  Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53 , 2004, Nature Genetics.

[13]  N. Mailand,et al.  Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation , 2002, Nature Cell Biology.

[14]  L Meijer,et al.  Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. , 1997, European journal of biochemistry.

[15]  Attila Tóth,et al.  APCCdc20 promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin Clb5 , 1999, Nature.

[16]  M. Brandeis,et al.  Cdk1 is essential for mammalian cyclosome/APC regulation. , 2000, Experimental cell research.

[17]  G L Trainor,et al.  Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation. , 2000, Journal of medicinal chemistry.

[18]  M. Sacristán,et al.  Functional Homology among Human and Fission Yeast Cdc14 Phosphatases* , 2005, Journal of Biological Chemistry.

[19]  Jian Kuang,et al.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation , 1998, Nature Genetics.

[20]  J N Weinstein,et al.  Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. , 1997, Cancer research.

[21]  Steven A. Carr,et al.  Phosphorylation by Cyclin B-Cdk Underlies Release of Mitotic Exit Activator Cdc14 from the Nucleolus , 2004, Science.

[22]  H. Saya,et al.  Aurora-A and an Interacting Activator, the LIM Protein Ajuba, Are Required for Mitotic Commitment in Human Cells , 2003, Cell.

[23]  P. Jackson,et al.  Xenopus Cdc14α/β are localized to the nucleolus and centrosome and are required for embryonic cell division , 2004, BMC Cell Biology.

[24]  J. Pines,et al.  Active cyclin B1–Cdk1 first appears on centrosomes in prophase , 2003, Nature Cell Biology.

[25]  J. Herman,et al.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.

[26]  E. Villa-Moruzzi,et al.  Differential Subcellular Localization of Protein Phosphatase-1 α, γ1, and δ Isoforms during Both Interphase and Mitosis in Mammalian Cells , 1998, The Journal of cell biology.

[27]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.

[28]  M. Ljungman,et al.  The Human Cdc14 Phosphatases Interact with and Dephosphorylate the Tumor Suppressor Protein p53* , 2000, The Journal of Biological Chemistry.

[29]  J. Herman,et al.  Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition. , 2000, Cancer research.

[30]  J. Dixon,et al.  A Family of Putative Tumor Suppressors Is Structurally and Functionally Conserved in Humans and Yeast* , 1997, The Journal of Biological Chemistry.

[31]  P. Jackson,et al.  Disruption of centrosome structure, chromosome segregation, and cytokinesis by misexpression of human Cdc14A phosphatase. , 2002, Molecular biology of the cell.

[32]  Anna Shevchenko,et al.  Exit from Mitosis Is Triggered by Tem1-Dependent Release of the Protein Phosphatase Cdc14 from Nucleolar RENT Complex , 1999, Cell.

[33]  H. O’Hagan,et al.  Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation , 2001, Oncogene.

[34]  J. Herman,et al.  Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. , 2001, Human molecular genetics.

[35]  B. Gabrielli,et al.  Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events. , 2000, Experimental cell research.

[36]  O. Bensaude,et al.  Inhibitors of transcription such as 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole and isoquinoline sulfonamide derivatives (H-8 and H-7) promote dephosphorylation of the carboxyl-terminal domain of RNA polymerase II largest subunit. , 1994, The Journal of biological chemistry.

[37]  C. Prives,et al.  Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases , 1995, Nature.

[38]  M. Balasubramanian,et al.  The Clp1p/Flp1p phosphatase ensures completion of cytokinesis in response to minor perturbation of the cell division machinery in Schizosaccharomyces pombe , 2004, Journal of Cell Science.

[39]  D. Teng,et al.  Genomic structure, chromosomal location, and mutation analysis of the human CDC14A gene. , 1999, Genomics.

[40]  H. Katayama,et al.  Interaction and Feedback Regulation between STK15/BTAK/Aurora-A Kinase and Protein Phosphatase 1 through Mitotic Cell Division Cycle* , 2001, The Journal of Biological Chemistry.

[41]  H. Lane,et al.  Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes , 1996, The Journal of cell biology.

[42]  R. White,et al.  BRCA1 is associated with the centrosome during mitosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Moreno,et al.  Flp1, a fission yeast orthologue of the s. cerevisiae CDC14 gene, is not required for cyclin degradation or rum1p stabilisation at the end of mitosis. , 2001, Journal of cell science.

[44]  H. F. Horn,et al.  Difference in the centrosome duplication regulatory activity among p53 ‘hot spot’ mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53 , 2001, Oncogene.

[45]  M. Balasubramanian,et al.  Cell cycle: The Flp side of Cdc14 , 2001, Current Biology.

[46]  K. Fukasawa,et al.  Loss of p53 and centrosome hyperamplification , 2002, Oncogene.

[47]  J. Bischoff,et al.  The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. , 1999, Trends in cell biology.

[48]  D. McCollum,et al.  Distinct Nuclear and Cytoplasmic Functions of the S. pombe Cdc14-like Phosphatase Clp1p/Flp1p and a Role for Nuclear Shuttling in Its Regulation , 2005, Current Biology.

[49]  F. Chen,et al.  Inhibition of RNA polymerase II as a trigger for the p53 response , 1999, Oncogene.

[50]  H. F. Horn,et al.  Nucleophosmin/B23 Is a Target of CDK2/Cyclin E in Centrosome Duplication , 2000, Cell.

[51]  G. Stein,et al.  Cell cycle independent interaction of CDC2 with the centrosome, which is associated with the nuclear matrix-intermediate filament scaffold. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Herman,et al.  Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. , 2001, Cancer research.

[53]  D. Morgan,et al.  Pds1 and Esp1 control both anaphase and mitotic exit in normal cells and after DNA damage. , 1999, Genes & development.

[54]  M. Tyers,et al.  Fission yeast Clp1p phosphatase regulates G2/M transition and coordination of cytokinesis with cell cycle progression , 2001, Current Biology.

[55]  H. O’Hagan,et al.  Nuclear accumulation of p53 following inhibition of transcription is not due to diminished levels of MDM2 , 2004, Oncogene.

[56]  Hongtao Yu,et al.  Regulation of the Anaphase-promoting Complex by the Dual Specificity Phosphatase Human Cdc14a* , 2001, The Journal of Biological Chemistry.

[57]  J. Herman,et al.  Synergistic activation of functional estrogen receptor (ER)-α by DNA methyltransferase and histone deacetylase inhibition in human ER-α-negative breast cancer cells , 2001 .

[58]  Angelika Amon,et al.  Closing mitosis: the functions of the Cdc14 phosphatase and its regulation. , 2004, Annual review of genetics.